Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93 USD | +2.50% | +7.08% | +0.82% |
Financials (USD)
Sales 2024 * | 393M | Sales 2025 * | 599M | Capitalization | 5.7B |
---|---|---|---|---|---|
Net income 2024 * | -340M | Net income 2025 * | -160M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 129M | Net cash position 2025 * | 38.3M | EV / Sales 2025 * | 9.44 x |
P/E ratio 2024 * |
-16.4
x | P/E ratio 2025 * |
-35.2
x | Employees | 655 |
Yield 2024 * |
-
| Yield 2025 * |
1.1% | Free-Float | 99.15% |
Latest transcript on Blueprint Medicines Corporation
1 day | +2.50% | ||
1 week | +7.08% | ||
Current month | -1.96% | ||
1 month | +3.71% | ||
3 months | +14.03% | ||
6 months | +68.42% | ||
Current year | +0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 93 | +2.50% | 725,952 |
24-04-25 | 90.73 | -1.66% | 755,177 |
24-04-24 | 92.26 | -0.03% | 588,540 |
24-04-23 | 92.29 | +1.85% | 788,709 |
24-04-22 | 90.61 | +4.33% | 792,073 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 5.56B | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- BPMC Stock